Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization [NA]
A study funded by the University of Texas at Austin to test interventions aimed at promoting tobacco cessation in individuals recently hospi…
-
FDA approval · 2024-05-07FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' supplemental application for a generic bupropion hydrochloride sustained-release product, expanding ac…
-
FDA approval · 2024-05-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
The FDA approved a supplemental application for a generic form of bupropion hydrochloride from Apnar Pharma LP, allowing continued marketing…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Financial Incentives for Smoking Treatment II [NA]
UCLA is conducting a trial evaluating financial incentives to support smoking cessation, with enrollment currently by invitation only.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Heart Rate Variability Biofeedback for Smoking Cessation Treatment [Phase 2]
A Phase 2 clinical trial evaluating heart rate variability biofeedback as a treatment for smoking cessation has completed enrollment and pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-30FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) submitted by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches [NA]
Clinical trial update indicates completion of a study to assess abuse liability for three nicotine pouch products sponsored by RAI Services …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes [NA]
The study evaluated nicotine pharmacokinetics after using the P4M3 Gen 2.0 e-cigarette compared with traditional cigarette smoking, with res…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Quit or Switch: E-cigarette Study [NA]
The clinical trial 'Quit or Switch: E-cigarette Study' has completed and posted results, investigating quitting strategies vs. switching in …
-
FDA approval · 2024-04-03FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Actavis) under an ANDA, approving the supplemental fi…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Switching to Potential Reduced Exposure Products in Adult Smokers [NA]
This Yale University-sponsored trial evaluates switching adult smokers to nicotine-containing oral pouch products as potential reduced expos…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers [Phase 1]
A Phase 1 bioequivalence study comparing 21 mg nicotine transdermal patches from two manufacturers, to assess interchangeability in healthy …
-
FDA approval · 2024-03-19FDA Approved: VARENICLINE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s Original Application for a generic varenicline tartrate tablet indicated to aid in smoking cessation.
-
FDA approval · 2024-03-15FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
FDA approved a supplemental application for QUITINE NICOTINE (nicotine polacrilex) from QUITINE LLC.
-
FDA approval · 2024-03-15FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
The FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) submitted by Strategic Sourcing Services LL…
-
FDA approval · 2024-03-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for EQUATE NICOTINE (nicotine polacrilex) submitted by Wal-Mart Stores Inc.
-
FDA approval · 2024-03-15FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Nicotine (nicotine polacrilex) under ANDA076789, representing an approved…
-
FDA approval · 2024-03-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex) from Wal-Mart Stores Inc, confirming its use as a nicotine…
-
FDA approval · 2024-03-15FDA Approved: BASIC CARE NICOTINE — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for BASIC CARE NICOTINE (nicotine polacrilex) submitted by Amazon.com Services LLC.
-
FDA approval · 2024-03-15FDA Approved: NICOTINE — Supplemental Application (H E B)
FDA approves a supplemental application for NICOTINE (nicotine polacrilex) from H E B, indicating an updated label or additional use for thi…
-
FDA approval · 2024-03-15FDA Approved: GOOD SENSE NICOTINE — Supplemental Application (L. Perrigo Company)
The FDA approved a supplemental application for Good Sense Nicotine (nicotine polacrilex) by L. Perrigo Company. This action confirms an upd…
-
FDA approval · 2024-03-06FDA Approved: VARENICLINE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved Marlex Pharmaceuticals' original application for varenicline tartrate, a smoking cessation aid.
-
FDA approval · 2024-02-29FDA Approved: VARENICLINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for a generic varenicline product for smoking cessation, manufactured by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects [Phase 4]
A Phase 4 trial assessing the effectiveness of combined tobacco treatment in hospitalized patients and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Examination of Low Wattage and High Wattage E-Cigarettes [NA]
A completed clinical trial evaluated the effects of low-wattage versus high-wattage electronic cigarettes. Results were posted on 2024-02-09…